Propiverine hydrochlorideOpens in new tab |
|
|
|
Reimbursement Review |
|
Complete |
SR0504-000 |
Yondelis for Liposarcoma or Leiomyoscarcoma – DetailsOpens in new tab |
|
|
|
Reimbursement Review |
|
Complete |
PC0071-000 |
Opdivo for Non-Small Cell Lung Cancer – DetailsOpens in new tab |
|
|
|
Reimbursement Review |
|
Complete |
PC0069-000 |
Avastin for Platinum-Resistant Ovarian Cancer – DetailsOpens in new tab |
|
|
|
Reimbursement Review |
|
Complete |
PC0066-000 |
ustekinumabOpens in new tab |
|
|
|
Reimbursement Review |
|
Complete |
SR0501-000 |
Fluorouracil and Salicylic AcidOpens in new tab |
|
|
|
Reimbursement Review |
|
Complete |
SR0498-000 |
Imbruvica for Mantle Cell Lymphoma (relapsed/refractory)Opens in new tab |
|
|
|
Reimbursement Review |
|
Complete |
PC0073-000 |
glycerol phenylbutyrateOpens in new tab |
|
|
|
Reimbursement Review |
|
Complete |
SR0497-000 |
Propranolol oral solutionOpens in new tab |
|
|
|
Reimbursement Review |
|
Complete |
SR0496-000 |
Ibrance for Advanced Breast Cancer – DetailsOpens in new tab |
|
|
|
Reimbursement Review |
|
Withdrawn |
PC0068-000 |
Cotellic for Metastatic Melanoma – DetailsOpens in new tab |
|
|
|
Reimbursement Review |
|
Complete |
PC0070-000 |
Adcetris for Hodgkin Lymphoma (post-ASCT consolidation) – DetailsOpens in new tab |
|
|
|
Reimbursement Review |
|
Withdrawn |
PC0086-000 |
Fentanyl buccalOpens in new tab |
|
|
|
Reimbursement Review |
|
Complete |
SR0494-000 |
EdoxabanOpens in new tab |
|
|
|
Reimbursement Review |
|
Complete |
SR0500-000 |
EdoxabanOpens in new tab |
|
|
|
Reimbursement Review |
|
Complete |
SR0499-000 |
Cyramza for Non-Small Cell Lung Cancer - DetailsOpens in new tab |
|
|
|
Reimbursement Review |
|
Cancelled |
PC0078-000 |
Idarucizumab (Drug Plan Submission)Opens in new tab |
|
|
|
Reimbursement Review |
|
Withdrawn |
SR0492-000 |
ReslizumabOpens in new tab |
|
|
|
Reimbursement Review |
|
Complete |
SR0495-000 |
LevofloxacinOpens in new tab |
|
|
|
Reimbursement Review |
|
Complete |
SR0493-000 |
Budesonide Opens in new tab |
|
|
|
Reimbursement Review |
|
Complete |
SR0491-000 |
Blinatumomab (Blincyto) for Ph- ALLOpens in new tab |
|
|
|
Reimbursement Review |
|
Complete |
PC0064-000 |
Opdivo for Metastatic Melanoma - DetailsOpens in new tab |
|
|
|
Reimbursement Review |
|
Complete |
PC0063-000 |
perindopril arginine / amlodipineOpens in new tab |
|
|
|
Reimbursement Review |
|
Complete |
SR0490-000 |
Guidance Document for the Costing of Health Care Resources in the Canadian Setting: Second EditionOpens in new tab |
|
|
|
Health Technology Review |
|
|
MH0002-CP0009 |
EmpagliflozinOpens in new tab |
|
|
|
Reimbursement Review |
|
Complete |
SR0488-000 |